Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

Measles Virus as An Oncolytic Vector Platform

(2008) Boris Blechacz et al.   CURRENT GENE THERAPY

A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein

(2008) J Conner et al.   GENE THERAPY

Oncolytic virotherapy as a personalized cancer vaccine

(2008) Qi-Xiang Li et al.   INTERNATIONAL JOURNAL OF CANCER

Cancer-killing Viruses Assist Gene Therapies

(2008) V. Brower et al.   JNCI-Journal of the National Cancer Institute

Immunotherapeutic potential of oncolytic virotherapy

(2008) Robin J Prestwich et al.   LANCET ONCOLOGY

Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer

(2008) Jeremy B Burton et al.   NATURE MEDICINE

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

(2008) Roberto Cattaneo et al.   NATURE REVIEWS MICROBIOLOGY

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

(2008) A. Kruschinski et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer

(2008) Michelle E Melisko et al.   Nature clinical practice. Oncology